JPRN-UMIN000010634已完成未知
Study for the efficacy and appropriate dosing of insulin degludec, an ultra long-acting insulin, in patients with type 1 diabetes - Study for the efficacy and appropriate dosing of insulin degludec, an ultra long-acting insulin, in patients with type 1 diabetes
Kitano Hospital, The Tazuke Kofukai Medical Research Institute0 个研究点目标入组 30 人开始时间: 2013年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. The patients who did not agree with this study 2. The patients with serious complications 3. The patients who are at high risk for hypoglycemia 4. The patients who have the history of severe hypoglycemia (needed an emergency transport according to the hypoglycemia unawareness) 5. Those who are not approved to be eligible to this study by corresponding researcher or co-researchers
研究者
相似试验
尚未招募
不适用
Clinical trial of Iron supplement in anemic pregnant women.CTRI/2022/11/047376Generex Pharmassist Pvt. Ltd.
已完成
2 期
Clinical evaluation of efficacy of dose-modified intravenous busulfan in allogeneic hematopoietic stem cell transplantation for hematological malignancy.Hematological malignancyJPRN-UMIN000014077Kyoto University Hospital, Department of Hematology and Oncology40
进行中（未招募）
1 期
Clinical study assessing safety and efficacy of Istaroxime in patients affected by acute cardiac insufficiency decompensated. Five centres will be involved. Each patient will receive, in a casual order, one of the two Istaroxime dosages or placebo and therefore there will be three different treatment groups. Nor the patients neither the doctors will know the treatment received/administered.EUCTR2013-000540-26-ITCVie Therapeutics Company Limited120
招募中
不适用
Investigation of clinical efficacy and safety of intramuscular administration of autologous total IgG therapy in patients with chronic urticariaDiseases of the skin and subcutaneous tissueKCT0006814Ajou University Hospital24
尚未招募
不适用
Homoeopathy for VitiligoCTRI/2022/03/041296Dr Neha Singhal